NCT07093528View on ClinicalTrials.gov

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

RecruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Heart Failure With Preserved Ejection FractionCoronary Microvascular Dysfunction
Interventions
DIAGNOSTIC_TEST

Cardiovascular Magnetic Resonance (CMR)

Patients will consent to undergo a 50-minute non-invasive stress perfusion CMR.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT07093528 - A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD | Biotech Hunter | Biotech Hunter